BBOT (BridgeBio Oncology Therapeutics) FFO


BBOT BridgeBio Oncology Therapeutics Inc BBOT
12 GF Score
Price $8.40
View Full Analysis

What is BridgeBio Oncology Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

BBOT
12GF Score
BridgeBio Oncology Therapeutics Inc BBOT
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BridgeBio Oncology Therapeutics Business Description

Address 256 East Grand Avenue, Suite 104, South San Francisco, CA, USA, 94080
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
12GF Score

Get the complete analysis for BBOT

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.40
Price